🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China SXT Pharmaceuticals” Clear

  1. 2mg Baricitinib

    China SXT Pharmaceuticals

    Acute Ichemic Stroke

    phase 3 small molecule active

    1 trial

  2. 5% Lidocaine patch

    China SXT Pharmaceuticals

    Herpes Zoster Pain

    phase 3 small molecule completed

    1 trial

  3. 5% cysteamine cream

    China SXT Pharmaceuticals

    Melasma

    phase 3 other completed

    1 trial

  4. 5-Fu/epirubicin/CTX following Docetaxel

    China SXT Pharmaceuticals

    Breast Cancer

    phase 3 small molecule active

    1 trial

  5. 68Ga-PSMA-11

    China SXT Pharmaceuticals

    Biochemical Recurrence of Malignant Neoplasm of Prostate

    phase 3 small molecule active

    1 trial

  6. ATLG

    China SXT Pharmaceuticals

    Hematopoietic Stem Cell Transplantation

    phase 3 small molecule active

    1 trial

  7. Adjuvant chemotherapy

    China SXT Pharmaceuticals

    Total Neoadjuvant Treatment

    phase 3 small molecule active

    1 trial

  8. Adjuvant immunotherapy

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  9. Almonertinib

    China SXT Pharmaceuticals

    Non-small Cell Lung Cancer Metastatic

    phase 3 small molecule active

    1 trial

  10. Amlodipine

    China SXT Pharmaceuticals

    Essential Hypertension

    phase 3 small molecule active

    1 trial

  11. Anterior Capsulotomy

    China SXT Pharmaceuticals

    Obsessive-Compulsive Disorder

    phase 3 other active

    1 trial

  12. Anti-PD-1 antibody drug named Serplulimab

    China SXT Pharmaceuticals

    Locally Advanced Rectal Cancer (LARC)

    phase 3 small molecule active

    1 trial

  13. Astragalus Membranaceus

    China SXT Pharmaceuticals

    Aneurysmal Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  14. Atropine sulfate eye drops 0.01%

    China SXT Pharmaceuticals

    Myopia

    phase 3 small molecule active

    1 trial

  15. Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

    China SXT Pharmaceuticals

    Obsessive Compulsive Disorder

    phase 3 other terminated

    1 trial

  16. Bisoprolol Fumarate

    China SXT Pharmaceuticals

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  17. Brentuximab Vedotin for Injection

    China SXT Pharmaceuticals

    Classical Hodgkin Lymphoma

    phase 3 small molecule active

    1 trial

  18. Buprenorphine Transdermal System

    China SXT Pharmaceuticals

    Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

    phase 3 small molecule completed

    1 trial

  19. Butylphthalide

    China SXT Pharmaceuticals

    Restenosis

    phase 3 small molecule completed

    1 trial

  20. Capecitabine

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  21. Capox chemotherapy

    China SXT Pharmaceuticals

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  22. Cardioblate® Surgical Ablation System

    China SXT Pharmaceuticals

    Rheumatic Valve Disease

    phase 3 other active

    1 trial

  23. Chickenpox Vaccines

    China SXT Pharmaceuticals

    Chickenpox Vaccines

    phase 3 mab completed

    1 trial

  24. Cisplatin

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources